GABA transporters as drug targets for modulation of GABAergic activity.
Schousboe
Arne
A
Department of Pharmacology, The Danish University of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen, Denmark. as@dfuni.dk
Sarup
Alan
A
Larsson
Orla M
OM
White
H Steve
HS
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D001692:Biological Transport; D016503:Drug Delivery Systems; D018755:GABA Agonists / Q000494:pharmacology; D050485:GABA Plasma Membrane Transport Proteins; D006801:Humans; D026901:Membrane Transport Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008968:Molecular Conformation; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009557:Nipecotic Acids / Q000494:pharmacology; D000078308:Tiagabine; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000737:chemistry*
D000927:Anticonvulsants; D018755:GABA Agonists; D050485:GABA Plasma Membrane Transport Proteins; D026901:Membrane Transport Proteins; D009557:Nipecotic Acids; C493413:SLC6A1 protein, human; C493418:SLC6A13 protein, human; C493414:Slc6a1 protein, mouse; D005680:gamma-Aminobutyric Acid; D000078308:Tiagabine